{"id":"https://openalex.org/W4361944036","doi":"https://doi.org/10.1158/1078-0432.c.6519876","title":"Data from Analysis of Fc\u03b3 Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients","display_name":"Data from Analysis of Fc\u03b3 Receptor IIIa and IIa Polymorphisms: Lack of Correlation with Outcome in Trastuzumab-Treated Breast Cancer Patients","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361944036","doi":"https://doi.org/10.1158/1078-0432.c.6519876"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6519876","doi":"https://doi.org/10.1158/1078-0432.c.6519876","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519876","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6519876","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068059897","display_name":"Sara Alsterlind Hurvitz","orcid":"https://orcid.org/0000-0001-7808-7191","observed_orcids":["https://orcid.org/0000-0001-7808-7191"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara A. Hurvitz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084596709","display_name":"David J. Betting","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David J. Betting","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028575353","display_name":"Howard Marvin Stern","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howard M. Stern","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035921302","display_name":"Emmanuel Quinaux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emmanuel Quinaux","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112051548","display_name":"Jeremy Stinson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy Stinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088898639","display_name":"Somasekar Seshagiri","orcid":"https://orcid.org/0000-0003-4272-6443","observed_orcids":["https://orcid.org/0000-0003-4272-6443"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Somasekar Seshagiri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119607044","display_name":"Ying Zhao","orcid":"https://orcid.org/0009-0009-5182-8100","observed_orcids":["https://orcid.org/0009-0009-5182-8100"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085474533","display_name":"Marc E Buyse","orcid":"https://orcid.org/0000-0002-4559-0994","observed_orcids":["https://orcid.org/0000-0002-4559-0994"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc Buyse","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032920417","display_name":"John Robert Mackey","orcid":"https://orcid.org/0000-0002-3489-2161","observed_orcids":["https://orcid.org/0000-0002-3489-2161"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Mackey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111919128","display_name":"Adrian Driga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrian Driga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023085450","display_name":"Sambasivarao Damaraju","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sambasivarao Damaraju","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114046059","display_name":"Mark X. Sliwkowski","orcid":"https://orcid.org/0009-0001-3656-3142","observed_orcids":["https://orcid.org/0009-0001-3656-3142"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark X. Sliwkowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075481530","display_name":"Nicholas J. Robert","orcid":"https://orcid.org/0000-0002-8491-5392","observed_orcids":["https://orcid.org/0000-0002-8491-5392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas J. Robert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080832682","display_name":"Vicente Valero","orcid":"https://orcid.org/0000-0001-5913-7480","observed_orcids":["https://orcid.org/0000-0001-5913-7480"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vicente Valero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043292277","display_name":"John Paul Crown","orcid":"https://orcid.org/0000-0002-3125-7613","observed_orcids":["https://orcid.org/0000-0002-3125-7613"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Crown","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085329460","display_name":"Carla Isadora Falkson","orcid":"https://orcid.org/0000-0003-2370-6818","observed_orcids":["https://orcid.org/0000-0003-2370-6818"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carla Falkson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044108002","display_name":"Adam Brufsky","orcid":"https://orcid.org/0000-0001-8080-7960","observed_orcids":["https://orcid.org/0000-0001-8080-7960","https://orcid.org/0009-0006-2725-3579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Brufsky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014491534","display_name":"Tadeusz Pie\u0144kowski","orcid":"https://orcid.org/0000-0002-0110-5950","observed_orcids":["https://orcid.org/0000-0002-0110-5950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tadeusz Pienkowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002412211","display_name":"Wolfgang EIERMANN","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Eiermann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100671433","display_name":"Miguel Mart\u00edn","orcid":"https://orcid.org/0000-0001-9237-3231","observed_orcids":["https://orcid.org/0000-0001-9237-3231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miguel Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065582989","display_name":"Valerie B\u00e9e","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Valerie Bee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051149549","display_name":"Omkar Subhash Marathe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Omkar Marathe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5107833759","display_name":"John M. Timmerman","orcid":"https://orcid.org/0000-0003-4104-8943","observed_orcids":["https://orcid.org/0000-0003-4104-8943"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John M. Timmerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.029100000858306885,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.9340000152587891},{"id":"https://openalex.org/keywords/fcgr2a","display_name":"FCGR2A","score":1.0},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.9670000076293945},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9210000038146973},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.9049999713897705},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6240000128746033},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.8315379023551941},{"id":"https://openalex.org/C153209595","wikidata":"https://www.wikidata.org/wiki/Q501128","display_name":"Single-nucleotide polymorphism","level":4,"score":0.5694100856781006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5659932494163513},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5051270127296448},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37656447291374207},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3473196029663086},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.34640443325042725},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3296951651573181},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.27975836396217346},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20169895887374878},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19290894269943237},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11918094754219055}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6519876","doi":"https://doi.org/10.1158/1078-0432.c.6519876","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519876","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6519876","doi":"https://doi.org/10.1158/1078-0432.c.6519876","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6519876","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2162904392","https://openalex.org/W4392691578","https://openalex.org/W2129397990","https://openalex.org/W1969826104","https://openalex.org/W2814801779","https://openalex.org/W7098907047","https://openalex.org/W4362617802","https://openalex.org/W2381088668","https://openalex.org/W1445806932","https://openalex.org/W2546973056"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"The":[2],"mechanisms":[3],"by":[4],"which":[5],"trastuzumab":[6,156,176,236],"imparts":[7],"clinical":[8],"benefit":[9],"remain":[10],"incompletely":[11],"understood.":[12],"Antibody-dependent":[13],"cellular":[14],"cytotoxicity":[15],"via":[16],"interactions":[17],"with":[18,62,75,81,129,179,257],"Fc\u03b3":[19],"receptors":[20],"(Fc\u03b3R)":[21],"on":[22],"leukocytes":[23],"may":[24],"contribute":[25],"to":[26,39,54,68],"its":[27],"antitumor":[28],"effects.":[29],"Single-nucleotide":[30],"polymorphisms":[31],"(SNP)":[32],"in":[33,96,137,143,150,173,238,254],"FCGR3A":[34,123],"and":[35,46,49,59,109,124,194,235,249,252],"FCGR2A":[36],"genes":[37],"lead":[38],"amino":[40],"acid":[41],"substitutions":[42],"at":[43],"positions":[44],"158":[45],"131,":[47],"respectively,":[48],"affect":[50],"binding":[51],"of":[52,99,133,140,175,181],"antibodies":[53],"Fc\u03b3R":[55],"such":[56],"that":[57,180],"158V/V":[58,218],"131H/H":[60,210,220],"bind":[61],"highest":[63],"affinity.":[64],"This":[65,227],"study":[66,184],"aimed":[67],"determine":[69],"whether":[70],"high-affinity":[71],"SNPs":[72,251],"are":[73],"associated":[74],"disease-free":[76],"survival":[77],"(DFS)":[78],"among":[79],"patients":[80,94,141,201,255],"HER2-positive":[82,239],"nonmetastatic":[83],"breast":[84,240],"cancer.":[85],"Experimental":[86],"Design:":[87],"Genomic":[88],"DNA":[89],"was":[90,104,152,177,197],"isolated":[91],"from":[92],"1,286":[93],"enrolled":[95],"a":[97,146,245],"trial":[98],"adjuvant":[100],"trastuzumab-based":[101],"chemotherapy.":[102],"Genotyping":[103],"conducted":[105],"using":[106],"Sanger":[107],"sequencing":[108],"Sequenom":[110],"mass":[111],"spectrometry.":[112],"Results:":[113],"Patient":[114],"samples":[115],"(N":[116],"=":[117,164,188,208,216,224],"1,189)":[118],"were":[119],"successfully":[120],"genotyped":[121,142],"for":[122,126,154,168,199],"1,218":[125],"FCGR2A.":[127],"Compared":[128],"the":[130,134,138,155,171,182,230],"overall":[131,183],"results":[132],"BCIRG006":[135],"study,":[136],"subset":[139],"this":[144],"analysis,":[145],"less":[147],"robust":[148],"improvement":[149],"DFS":[151,193,253],"observed":[153],"arms":[157],"than":[158],"control":[159],"arm":[160],"(HR,":[161,185],"0.842;":[162],"P":[163,187,207,215,223],"0.1925).":[165],"When":[166],"stratified":[167],"prognostic":[169],"features,":[170],"HR":[172],"favor":[174],"consistent":[178],"0.74;":[186],"0.036).":[189],"No":[190],"correlation":[191,246],"between":[192,232,247],"FCGR3A/2A":[195,233],"genotypes":[196,234],"seen":[198],"trastuzumab-treated":[200],"(158V/V":[202],"vs.":[203,205,211,213,221],"V/F":[204],"F/F,":[206],"0.98;":[209],"H/R":[212],"R/R,":[214],"0.76;":[217],"and/or":[219],"others,":[222],"0.67).":[225],"Conclusion:":[226],"analysis":[228],"evaluating":[229],"association":[231],"efficacy":[237],"cancer":[241],"did":[242],"not":[243],"show":[244],"FCGR3A-V/F":[248],"FCGR2A-H/R":[250],"treated":[256],"trastuzumab.":[258],"Clin":[259],"Cancer":[260],"Res;":[261],"18(12);":[262],"3478\u201386.":[263],"\u00a92012":[264],"AACR.":[265]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2023-04-05T00:00:00"}